Anafilaksiya: klyuchevye aspekty diagnostiki, lecheniya i profilaktiki v sovremennykh klinicheskikh rukovodstvakh


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Due to growing number of unpredictable, life-threatening, fast-developing cases of anaphylaxis in all age groups, doctors of all specialties focus on the key issues of assessment of individual risk factors, recognition of clinical symptoms and the choice of strategies for interventions aimed to improvement of management and prognosis of potentially fatal anaphylactic reactions. The importance of the issues is highlighted in numerous publications on the diagnosis, treatment and prevention of anaphylaxis, including illustrated clinical guidance on anaphylaxis 2011. This document of World Allergy Organization included recommendations of more than 100 leading experts from all over the world and based on the best evidence-based research data, was supplemented with new information in 2012. The article presents the fundamental principles of the guidelines, which doctor of any specialty needs to know. These include clinical criteria for the diagnosis of anaphylaxis, the need for use of epinephrine as a first-line drug in anaphylaxis, advanced laboratory diagnostic methods for asymptomatic sensitization, new strategies of immunomodulation for the prevention of nutritional and insect anaphylaxis, and debating issues of the use of corticosteroids and antihistamines

Толық мәтін

Рұқсат жабық

Әдебиет тізімі

  1. Simons FER, Ardusso LR, Bilo MB, et al. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. World Allergy Organ J 2011;4:13-36.
  2. Simons FER, Ardusso LR, Bilo MB, et al. 2012 Update: World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12:389-99.
  3. Аллергология и иммунология: национальное руководство / Под ред. Р.М. Хаитова, НИ. Ильиной. М., 2009. С. 482-91.
  4. Sheikh A, Shehata YA, Brown SG, et al. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2008;4.
  5. Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007:62:857-71.
  6. Kirkbright SJ, Brown SG. Anaphylaxis - recognition and management. Aust Fam Physician 2012;41 (6):366- 70.
  7. Simons FER. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol 2009;124:625-36.
  8. Greenberger PA, Ditto AM. Chapter 24: Anaphylaxis. Allergy Asthma Proc 2012;33(Suppl 1):S80-83.
  9. Blatman KH, Ditto AM. Chapter 25: Idiopathic anaphylaxis. Allergy Asthma Proc 2012;33(Suppl 1):S84-87.
  10. Simons FE. Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened? Curr Opin Allergy Clin Immunol 2010; 10(4):384-93.
  11. Caton EJ, Flynn M. Management of anaphylaxis in the ED: A clinical audit. Int Emerg Nurs 2013;21(1):64-70.
  12. Russell S, Monroe K, Losek JD. Anaphylaxis management in the pediatric emergency department: opportunities for improvement. Pediatr Emerg Care 2010;26(2):71-6.
  13. Huang F, Chawla K, Järvinen KM, Nowak- WögrzynA. Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes. J Allergy Clin Immunol 2012; 129( 1 ): 162-68.
  14. Decker WW, Campbell RL, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008;122:1161-65.
  15. Bohlke K, Davis RL, DeStefano F, et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004;113:536-42.
  16. Dinakar Ch. Anaphylaxis in Children: Current Understanding and Key Issues in Diagnosis and Treatment. Curr Allergy Asthma Rep 2012;12(6):641 -49.
  17. Worm M. Epidemiology of Anaphylaxis. Chem Immunol Allergy 2010;95:12-21.
  18. Gaeta TJ, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol 2007;98:360-65.
  19. Ross MP, Ferguson M, Street D, et al. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy ClinImmunol 2008;121:166-71.
  20. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics 2009; 124:1549-55.
  21. Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 2011 ;128:e9-17.
  22. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007;119:1016-18.
  23. Hockenhull J, Elremeli M, Cherry MG, et al. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy. Health Technol Assess 2012;16(12):1-110.
  24. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191-98.
  25. Rudders SA, Banerji A, Corel B, Clark S, Camargo CA Jr. Multicenter study of repeat epinephrine treatment for food-related anaphylaxis. Pediatrics 2010;125:e711-18.
  26. Wolver SE, Sun DR, Commins SP, Schwartz LB. A peculiar cause of anaphylaxis: no more steak? The journey to discovery of a newly recognized allergy to galactose-alpha- 1,3-galactose found in mammalian meat. J Gen Intern Med 2013;28(2):322-25.
  27. Saleh H, Embry S, Nauli A, Atyia S, Krishnaswamy G. Anaphylactic reactions to oligosaccharides in red meat: a syndrome in evolution. Clin Mol Allergy 2012;10(1):5.
  28. Федоскова Т.Г. Аллергия к насекомым. Современные принципы диагностики и лечения. http://rmj.ru
  29. Tracy JM, Khan FS, Demain JG. Insect anaphylaxis: where are we? The stinging facts 2012. Curr Opin Allergy Clin Immunol 2012;12(4):400-5.
  30. Vovolis V, Kalogiros L, Mitsias D, Sifnaios E. Severe repeated anaphylactic reactions to sublingual immunotherapy. Allergol Immunopathol (Madr) 2012, Dec 17.
  31. Lieberman P. The risk and management of anaphylaxis in the setting of immunotherapy. Am J Rhinol Allergy 2012;26(6):469-74.
  32. Cronin J, Scorr A, Russell S, et al. A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis. Acta Paediatr 2012;101 (9):941 -45.
  33. Астафьева Н.Г. Гамова И.В., Кобзев Д.Ю., Удовиченко Е.Н., Перфилова И.А. Лекарственная гиперчувствительность при оперативных вмешательствах // Лечащий врач 2011. № 4. С. 6-12.
  34. Астафьева Н.Г. Гамова И.В., Горячкина Л.А. и др. Анафилаксия: от экспериментальных исследований Рише к современным клиническим руководствам//Доктор.ш 2011. № 3. С. 7-14.
  35. Norred CL. Anesthetic-induced anaphylaxis. AANA J 2012;80(2): 129-40.
  36. Povesi Dascola C, Caffarelli C. Exercise-induced anaphylaxis: A clinical view. Ital J Pediatr 2012;38:43.
  37. Marrs T, Lack G. Why do few food-allergic adolescents treat anaphylaxis with adrenaline? - reviewing a pressing issue. Pediatr Allergy Immunol 2012, Nov 22.
  38. Gallagher M, Worth A, Cunningham-Burley S, Sheikh A. Strategies for living with the risk of anaphylaxis in adolescence: qualitative study of young people and their parents. Prim Care Respir J 2012;21(4):392-97.
  39. Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012;130(3):597-606.
  40. Park HJ, Kim SH. Factors associated with shock in anaphylaxis. Am J Emerg Med 2012;30(9): 1674-78.
  41. Worm M, Edenharter G, Ruеff F, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012;67(5):691 -98.
  42. Campbell RL, Hagan JB, Li JT, et al. Anaphylaxis in emergency department patients 50 or 65 years or older. Ann Allergy Asthma Immunol 2011;106(5):401-6.
  43. Triggiani M, Patella V, Staiano RI, Granata F, Marone G. Allergy and the cardiovascular system. Clin Exp Immunol 2008;153(Suppl 1):7-11.
  44. Andersen CL, Kristensen TK, Severinsen MT, et al. Systemic mastocytosis - a systematic review. Dan Med J 2012;59(3):A4397.
  45. Worm M, Babina M, Hompes S. Causes and risk factors for anaphylaxis. J Dtsch Dermatol Ges 2012;11(1):44-50.
  46. Santos AF, Lack G. Food allergy and anaphylaxis in pediatrics: update 2010-2012. Pediatr Allergy Immunol 2012;23(8):698-706.
  47. Moneret-Vautrin DA. Drugs as risk factors of food anaphylaxis in adults. Med Sci (Paris) 2010;26(8-9):719-23.
  48. Vadas P, Perelman B, Liss G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol 2013;131(1):144-49.
  49. Ponvert C. Allergic and non-allergic hypersensitivity to non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory drugs in children: epidemiology, clinical aspects, pathophysiology, diagnosis and prevention. Arch Pediatr 2012;19(5):556-60.
  50. Mancardi DA, Albanesi M, Jonsson F, et al. The high-affinity human IgG receptor FcyRI (CD64) promotes IgG-mediated inflammation, anaphylaxis and anti-tumor immunotherapy. Blood 2013; 121(9):1563-73.
  51. Емельянов А.В. Анафилактический шок // Российский аллергологический журнал. 2005. Приложение. 28 с.
  52. Ring J, Grosber M, Mohrenschlager M, Brockow K. Anaphylaxis: acute treatment and management. Chem Immunol Allergy 2010;95:201-10.
  53. Farnam K, Chang C, Teuber S, Gershwin ME. Nonallergic drug hypersensitivity reactions. Int Arch Allergy Immunol 2012; 159(4):32 7-45.
  54. Caimmi S, Caimmi D, Bousquet PJ, Demoly P. How can we better classify NSAID hypersensitivity reactions? - validation from a large database. Int Arch Allergy Immunol 2012; 159(3):306-12.
  55. Greenberger PA. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 2007;27:273-93.
  56. Blatman KH, Ditto AM. Chapter 25: Idiopathic anaphylaxis. Allergy Asthma Proc 2012;33(Suppl 1):S84-87.
  57. Pushparaj PN, Tay HK, H'ng SC, et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci USA 2009;106:9773-78.
  58. Glowania A, Goebel U, Klimek L. Management of anaphylaxis. Part 1: Causes and pathophysiology. HNO 2012;60(11):1019-28.
  59. Freichel M, AlmeringJ, Tsvilovskyy V. The Role of TRP Proteins in Mast Cells. Front Immunol 2012;3:150.
  60. Smith PK, Nilius B. Transient Receptor Potentials (TRPs) and Anaphylaxis. Curr Allergy Asthma Rep 2012;13(1):93-100.
  61. Campbell RL, Hagan JB, Manivannan V, et al. Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol 2012;129:748-52.
  62. Harduar-Morano L, Simon MR, Watkins S, Blackmore C. Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 2010; 126:98-104.
  63. Arnold JJ, Williams PM. Anaphylaxis: Recognition and Management. Am Fam Physician 2011;84(10):1111-18.
  64. GLORIA Module 8: Anaphylaxis WAO Expert Panel Lockey RF, Kaliner MA, Simons FER, Motala C, Lanier B. Additional contributor: Sheikh A.
  65. Simons FE. Anaphylaxis pathogenesis and treatment. Allergy 2011;66( Suppl 95):31 -4.
  66. Andersen CL, Kristensen TK, Severinsen MT, et al. Systemic mastocytosis - a systematic review. Dan Med J 2012;59(3):A4397.
  67. Banerji A, Rudders SA, Corel B, et al. Predictors of hospital admission for food-related allergic reactions that present to the emergency department. Ann Allergy Asthma Immunol 2011;106(1):42-8.
  68. Rutkowski K, Dua S, Nasser S. Anaphylaxis: current state of knowledge for the modern physician. Postgrad Med J 2012;88(1042):458-64.
  69. Klimek L, Goebel U, Glowania A. Management of anaphylaxis: Part 2: Treatment and emergency equipment. HNO 2012;60(12):1103-13.
  70. Sheikh A, Simons FE, Barbour V, Worth A. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community. Cochrane Database Syst Rev 2012;8.
  71. Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev 2012;4.
  72. Sheikh A, ten Broek VM, Brown SG, Simons FE. H1 -antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2007;1.
  73. Lieberman JA, Chehade M. Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis. Curr Allergy Asthma Rep 2013;13(1):78-84.
  74. Simons FE. Anaphylaxis. J Allergy Clin Immunol 2010; 125(2 Suppl 2):S 161-81.
  75. Simons E, Sicherer SH, Simons FE. Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective. Ann Allergy Asthma Immunol 2012; 108(5):321 -25.
  76. Frew AJ. What are the "ideal" features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis? Allergy 2011;66(1): 15-24.
  77. Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011;127:654-60.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>